The effect of low level laser therapy on vision in patients with retinitis pigmentosa
- Conditions
- Retinitis pigmentosaEye - Diseases / disorders of the eyeHuman Genetics and Inherited Disorders - Other human genetics and inherited disorders
- Registration Number
- ACTRN12618000651280
- Lead Sponsor
- The Royal Adelaide Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 12
•Age 18 years or older
•Visual acuity between 6/12 and 6/240 (letters 77 – 4) and the decreased vision is attributed to RP and not explained by any other cause
•Any eye with an intraocular surgical or laser procedure within 6 months
•Patient has a condition or is in a situation that in the investigator’s opinion may put the patient at significant risk, may confound the study results, or may interfere significantly with the patient’s participation in the study
•Women who are pregnant, nursing, or planning a pregnancy, or who are of childbearing potential and not using reliable means of contraception. A woman is considered of childbearing potential unless she is postmenopausal and without menses for 12 months or is surgically sterilised
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measure will be the safety profile , safety defined by the absence of adverse events.<br>Any experience of adverse events will be asked by the clinical trial coordinator at each visit the patient has, with the responses documented in the patient notes.<br>Contact details will be provided to the patients should they need to report any adverse events outside of these visits.<br>CTCAE will be used to grade any serious adverse events by the ophthalmologists reviewing the patients. [4 weeks and 6 month safety review]
- Secondary Outcome Measures
Name Time Method